Researchers from the UCLA Health Jonsson Comprehensive Cancer Center have received a $1.7 million grant from the US Department of Defense’s Congressionally Directed Medical Research Programs to develop new strategies to improve CAR T-cell therapies for metastatic CRPC. [UCLA Health] Press Release
This story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.